Anand Reddy, MD
Nephrology · Odessa, TXNPI 1780892760
Payments from drug & device makers
Across 980 payments — averaging $560.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$156K
- Calliditas Therapeutics US Inc.$97K
- Amgen$93K
- Travere Therapeutics, Inc.$41K
- Lilly USA, LLC$33K
- Akebia Therapeutics Inc$24K
- plus $105K from 25 others
Across 2 payments — averaging $1183.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 157 | $156,030 |
| Calliditas Therapeutics US Inc. | 98 | $97,228 |
| Amgen(2 entities) | 146 | $92,929 |
| Travere Therapeutics, Inc. | 104 | $40,913 |
| Lilly USA, LLC | 37 | $32,709 |
| Akebia Therapeutics Inc | 36 | $24,048 |
| Fresenius USA Marketing, Inc. | 42 | $21,738 |
| Ardelyx, Inc. | 23 | $19,709 |
| Vifor Pharma, Inc. | 66 | $19,666 |
| Boehringer Ingelheim | 63 | $17,520 |
| Scpharmaceuticals Inc. | 17 | $9,955 |
| ANI Pharmaceuticals, Inc. | 14 | $9,150 |
| American Regent | 1 | $4,160 |
| OPKO Pharmaceuticals, LLC | 80 | $1,268 |
| Otsuka America Pharmaceutical, Inc. | 18 | $400 |
| Bayer | 14 | $325 |
| GSK | 11 | $238 |
| Aurinia Pharma U.S., Inc. | 10 | $210 |
| Novartis | 6 | $188 |
| Lexicon Pharmaceuticals, Inc. | 11 | $179 |
| Mallinckrodt Hospital Products Inc. | 11 | $178 |
| Outset Medical Inc | 2 | $93 |
| Shire North American Group Inc | 1 | $89 |
| Genentech USA, Inc. | 4 | $71 |
| AbbVie | 1 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $51 |
| Sanofi-aventis U.S. LLC | 1 | $46 |
| Baxter Healthcare | 2 | $35 |
| Sanofi | 1 | $25 |
| Philips North America LLC | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
How this compares
$549,262 in reported general payments places this provider in the 95th percentile of 1,070 nephrology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Odessa
- Pablo PergolaSan Antonio$14.2M
- German HernandezEl Paso$9.7M
- Sreedhar MandayamHouston$7M
- Tahira AlvesSan Antonio$6.1M
- Carl DukesSan Antonio$5.9M
- Chinonye Ogbonnaya-OdorSan Antonio$4.6M
- Marializa BernardoHouston$4.2M
- Judith BettsAustin$3.7M
- Wesley CalhounSan Antonio$3.5M
- Adam FromeThe Woodlands$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.